Advanced search
Publication Cover
Modern Rheumatology Volume 12, 2002 - Issue 3
Journal homepage
31
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Gastrointestinal symptoms associated with enteric-coated sulfasalazine (Azulfidine EN tablets)

S. OkuboDepartment of Rheumatology, Misato Marine Hospital, 1617-5 Niida, Kochi 781-0112, Japan
,
K. NakataniDepartment of Orthopedic Surgery, Misato Marine Hospital, Kochi, Japan
&
K. NishiyaNishiya Internal Clinic, Hiroshima, Japan
Pages 226-229 | Received 11 Oct 2001, Accepted 29 Mar 2002, Published online: 02 Jan 2014

References

  • Svartz N. Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 1942;110:577–98.
  • Svartz N. The treatment of rheumatic polyarthritis with acid azo compounds. Rheumatism 1948;4:56–60.
  • McConkey B, Amos RS, Buther EP, Durham S, Forster PJG, Hubball S, et al. Sulphasalazine in rheumatoid arthritis. BMJ 1979;280:442–4.
  • Abramson J, James DS, McManus JP, Hightower NC. Ameliora-tion of sulphasalazine-associated gastric intolerance by use of en-teric-coated tablets. Pract Gastroenterol 1988;12:32–9.
  • Weaver A, Chatwell R, Churchill M, Kastanek L, Beyene J, Garceau R, et al. Improved gastrointestinal tolerance and patient preference of enteric-coated sulfasalazine versus uncoated sulfasalazine tablets in patients with rheumatoid arthritis. J Clin Ftheumatol 1999;5:193–200.
  • Goronzy JJ, Weyand CM. Rheumatoid arthritis (in Japanese). In: Klippel JH, editor. Primer on the rheumatic diseases. 11th ed. Atlanta: William M. Otto; 1997. p. 214–22.
  • Nishioka K, Nobunaga T, Sakuma A. A double blind comparative study between sulphasalazine enteric tablet (PJ-306) and placebo: dose finding study, 1 g, 2 g/day and placebo (in Japanese). Ryumachi 1991;31: 327–45.
  • Gran JT, Myklebust G. Toxicity of sulphasalazine in rheumatoid arthritis: possible protective effect of rheumatoid factors and corti-costeroids. Scand J Ftheumatol 1993;22:229–32.
  • Amos RS, Pullar T, Box DE, Situnayake D, Capell HA, McConkey B. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. BMJ 1983;293:420–3.
  • Skosey JR. Comparison of responses to and adverse effects of graded doses of sulphasalazine in the treatment of rheumatoid arthritis. J Ftheumatol 1988;15 (Suppl 16):5–8.
  • Okubo S, Kondoh M, Nakatani K. Shock and lupus-like syndrome induced by sulfasalazine (SASP) in patients with rheumatoid arthritis (in Japanese). Clin Ftheumatol 1997;9:113–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.